FBONX
Price
$41.06
Change
+$0.16 (+0.39%)
Updated
Aug 21 closing price
Net Assets
282.59B
MNECX
Price
$20.16
Change
+$0.07 (+0.35%)
Updated
Aug 21 closing price
Net Assets
359.93M
Interact to see
Advertisement

FBONX vs MNECX

FBONX vs MNECX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBONX has more cash in the bank: 283B vs. MNECX (360M). FBONX pays higher dividends than MNECX: FBONX (2.06) vs MNECX (1.21). FBONX was incepted earlier than MNECX: FBONX (6 years) vs MNECX (17 years). MNECX (1.80) is less costly to investors than FBONX (0.30). MNECX is a more actively managed with annual turnover of: 78.00 vs. FBONX (50.00). FBONX has a lower initial minimum investment than MNECX: FBONX (250) vs MNECX (2000). FBONX annual gain was more profitable for investors over the last year : 12.96 vs. MNECX (0.79). FBONX return over 5 years is better than : 37.83 vs. MNECX (-7.68).
FBONXMNECXFBONX / MNECX
Total Expense Ratio0.301.8017%
Annual Report Gross Expense Ratio0.301.8017%
Fund Existence6 years17 years-
Gain YTD10.3074.828213%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets283B360M78,611%
Annual Yield % from dividends2.061.21170%
Returns for 1 year12.960.791,647%
Returns for 3 years46.3117.39266%
Returns for 5 years37.83-7.68-493%
Returns for 10 yearsN/A-1.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIOT0.760.06
+9.01%
Viomi Technology Co Ltd
LYEL15.530.18
+1.17%
Lyell Immunopharma Inc
BPYPP16.430.05
+0.32%
Brookfield Property Partners LP
KYMR119.80-1.70
-1.40%
Kymera Therapeutics
NVCR17.10-0.67
-3.77%
NovoCure Limited